Sitbon David, Podsypanina Katrina, Yadav Tejas, Almouzni Geneviève
Institut Curie, PSL Research University, CNRS, UMR3664, Equipe Labellisée Ligue contre le Cancer, Paris, France.
Sorbonne Universités, UPMC Univ Paris 06, CNRS, UMR3664, Paris, France.
Cold Spring Harb Symp Quant Biol. 2017;82:1-14. doi: 10.1101/sqb.2017.82.033753. Epub 2017 Dec 5.
Chromatin organization in the nucleus provides a vast repertoire of information in addition to that encoded genetically. Understanding how this organization impacts genome stability and influences cell fate and tumorigenesis is an area of rapid progress. Considering the nucleosome, the fundamental unit of chromatin structure, the study of histone variants (the bricks) and their selective loading by histone chaperones (the architects) is particularly informative. Here, we report recent advances in understanding how relationships between histone variants and their chaperones contribute to tumorigenesis using cell lines and development as model systems. In addition to their role in histone deposition, we also document interactions between histone chaperones and other chromatin factors that govern higher-order structure and control DNA metabolism. We highlight how a fine-tuned assembly line of bricks (H3.3 and CENP-A) and architects (HIRA, HJURP, and DAXX) is key in adaptation to developmental and pathological changes. An example of this conceptual advance is the exquisite sensitivity displayed by p53-null tumor cells to modulation of HJURP, the histone chaperone for CENP-A (CenH3 variant). We discuss how these findings open avenues for novel therapeutic paradigms in cancer care.
细胞核中的染色质组织除了提供遗传编码的信息外,还提供了大量的信息。了解这种组织如何影响基因组稳定性、影响细胞命运和肿瘤发生是一个快速发展的领域。考虑到核小体作为染色质结构的基本单位,对组蛋白变体(砖块)及其由组蛋白伴侣(建筑师)进行的选择性装载的研究尤其具有启发性。在这里,我们报告了利用细胞系和发育作为模型系统,在理解组蛋白变体与其伴侣之间的关系如何促进肿瘤发生方面的最新进展。除了它们在组蛋白沉积中的作用外,我们还记录了组蛋白伴侣与其他染色质因子之间的相互作用,这些因子控制着高阶结构并调控DNA代谢。我们强调了由砖块(H3.3和CENP - A)和建筑师(HIRA、HJURP和DAXX)组成的精细装配线如何在适应发育和病理变化中发挥关键作用。这一概念进展的一个例子是p53缺失的肿瘤细胞对CENP - A(CenH3变体)的组蛋白伴侣HJURP的调节表现出的高度敏感性。我们讨论了这些发现如何为癌症治疗的新治疗模式开辟道路。